BioNTech SE and Pfizer (PFE) recently received a positive recommendation from the European Medicines Agency for marketing ...

Pfizer is cutting costs, growing its core business, and trading at a deep discount despite looming patent losses and COVID ...

Pfizer Inc. (NYSE: PFE) announced today the completion of a global, ex-China, licensing agreement with 3SBio, Inc. (01530.HK) ...

The appointment of a seasoned pharmaceutical executive, George Tidmarsh, to run the FDA’s drug center underscores the ...

A Texas man is suing a California doctor for allegedly providing his girlfriend with abortion medication. The lawsuit—a civil ...

Pfizer (PFE) is currently under significant scrutiny due to a study linking its product, Depo-Provera, to increased health risks, and an associated Multi-District Litigation could have influenced its ...

Arizona Congressman Paul Gosar is reintroducing legislation that will let people sue vaccine makers if they believe a vaccine ...

Lepore starts Aug. 18 at Air Products, which has 23,000 employees spread across 50 countries and ranks 347th in the Fortune ...

Litigation over state power to regulate pharmacy benefit managers is far from over, even after the US Supreme Court bolstered ...

"I think the common thread is probably that there's a person that's been victimized or discarded or forgotten about by a ...

Most of America was blissfully unaware of the havoc wreaked by urban renewal until Kelo, when the veil was lifted. Anybody’s ...